Febrile Illness in Kinshasa and Kimpese (FIKI²)
Clinical Aspects, Severity, Management and Outcome of Febrile Illnesses in the Democratic Republic Congo (DRC).
Sponsor: Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Listed as NCT04760678, this observational or N/A phase trial focuses on Febrile Illness and remains completed. Sponsored by Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo, it has been updated 10 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Apr 2025 — Sep 2025 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Sep 2024 — Apr 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Nov 2023 — Apr 2024 [monthly]
Recruiting
-
Apr 2023 — Nov 2023 [monthly]
Recruiting
-
Apr 2022 — Apr 2023 [monthly]
Recruiting
-
Sep 2021 — Apr 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
- Institute of Tropical Medicine, Belgium
For direct contact, visit the study record on ClinicalTrials.gov .